Back to Top Skip to main content

World AIDS Day puts spotlight on landmark DoD study

Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo) Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration. (U.S. Army photo)

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

The Walter Reed Army Institute of Research (WRAIR) hosted a World AIDS Day event Tuesday, Nov. 26, highlighting advances in DoD-led HIV research and celebrating the 10th anniversary of the Army-led RV144 HIV vaccine study.

WRAIR’s Military HIV Research Program or MHRP headed the RV144 study, the first-ever – and only to-date – clinical trial to demonstrate that an HIV vaccine regimen was safe and modestly effective in preventing HIV infection. The study sought to determine what methods could be used to lower risk of contracting the disease.

The RV144 trial represented a massive undertaking for the Army and serves as a model of international and interagency collaboration. It involved more than 16,000 adult volunteers and a large network of partners who still work with WRAIR today, including the Thai Ministry of Public Health; the National Institute of Allergy and Infectious Diseases – part of the National Institutes of Health; and Sanofi Pasteur.

In 2009, the Army announced that the study’s investigational prime-boost vaccine regimen lowered the rate of HIV infection by 31.2 percent. These results, although modest, gave the global community hope that a vaccine to prevent HIV infection is possible at a time when such an achievement seemed elusive.

“RV144 was the light at the time in the field, without which we may have given up,” said Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center and the featured speaker at WRAIR’s World AIDS Day event. “In the last 10 years of HIV vaccine progress, RV144 is the anchor.”

The landmark trial continues to provide scientific direction to help guide vaccine development and testing. RV144 and its follow-on trials allowed researchers to discover of risk factors, provide targets for optimizing vaccine boosting, and form a foundation for three HIV vaccine candidates currently undergoing efficacy testing. A video featuring many prominent HIV researchers who were involved with RV144 was shown at the World AIDS Day event.

Also at the event, Lt. Gen (Ret.) Eric B. Schoomaker, 42nd surgeon general of the United States Army and former commanding general of the United States Army Medical Command, highlighted the military’s earliest contributions to HIV research, which include the development of a disease staging system and promoting the finding that HIV can be transmitted heterosexually. The military’s HIV research efforts were consolidated in 1986 with the establishment of MHRP.

MHRP’s initial mission was to advance an HIV vaccine to protect service members and the global community from HIV, but has since expanded beyond vaccine development to include cure research and prevention and treatment services in Africa under the President’s Emergency Plan for AIDS Relief or PEPFAR. Via PEPFAR initiatives, WRAIR provides life-saving antiretroviral therapy to more than 350,000 people living with HIV in sub-Saharan Africa, which contributes to global health security.

WRAIR supports PEPFAR activities within military and civilian communities in four countries where it conducts research (Nigeria, Tanzania, Uganda, and Kenya), which strengthens community trust and provides an ethical framework for clinical studies. The Department of Defense HIV/AIDS Prevention Program, led by the U.S. Navy, is responsible for assisting foreign military partners with the development and implementation of military-specific HIV/AIDS prevention and treatment programs in more than 55 countries around the globe, also supported by PEPFAR.

“Those countries that partner with us on PEPFAR have a 40-percent decrease in violence and a 40-increase in political stability,” said WRAIR Commander Army Col. Deydre Teyhen. “So we say that soldier health is world health. But in fighting HIV/AIDS, WRAIR researchers are also working to advance world peace.”

More information can be found on the RV144 HIV Trial web page.

You also may be interested in...

Defense Health Agency Overview

Presentation
2/9/2017

Defense Health Agency Overview

Recommended Content:

Military Medical History | Research and Innovation

Decision Brief Improving Defense Health Program Medical Research Processes

Presentation
2/9/2017

Decision Brief: Public Health Subcommittee Improving Defense Health Program Medical Research Processes

Recommended Content:

Research and Innovation

Overview of Air Force Medical Service

Presentation
2/9/2017

Overview of Air Force Medical Service

Recommended Content:

Research and Innovation | Military Medical History

Classifying the Histomorphology of Prostatic Adenocarcinoma with Deep Neural Networks

Presentation
11/1/2016

Classifying the Histomorphology of Prostatic Adenocarcinoma with Deep Neural Networks

Recommended Content:

Research and Innovation | Technology

Innovations from a Global Health Engagement and Rapid Response during Ebola virus outbreak

Presentation
11/1/2016

Innovations from a Global Health Engagement and Rapid Response during the 2013-2015 Western African Ebola virus outbreak. Briefing to the Defense Health Board, Nov. 1, 2016.

Recommended Content:

Global Health Engagement

Improving Defense Health Program Medical Research Processes

Presentation
11/1/2016

Improving Defense Health Program Medical Research Processes briefing to the Defense Health Board, Nov. 1, 2016.

Recommended Content:

Research and Innovation

Mechanical Ventilation Methods in Transport of Critically Injured Patients

Presentation
11/1/2016

Mechanical Ventilation Methods in Transport of Critically Injured Patients

Recommended Content:

Access, Cost, Quality, and Safety | Research and Innovation

A National Trauma Care System

Presentation
8/9/2016

A National Trauma Care System: Integrating Military and Civilian Trauma Systems to Achieve Zero Preventable Deaths After Injury

Recommended Content:

Health Readiness | Research and Innovation | Access, Cost, Quality, and Safety

Pediatric Clinical Preventive Services

Presentation
8/9/2016

Recommended Content:

Research and Innovation | Conditions and Treatments

Enterprise Intelligence Branch/MHS Population Health Portal

Presentation
8/9/2016

The first part of this presentation discusses the Enterprise Intelligence Branch, which supports the MHS strategic goals through delivery of timely, relevant, and actionable information toa ll levels of the organization. The second part describes the MHS Poulation Health Portal and shows examples.

Recommended Content:

Technology | Research and Innovation

Improving Defense Health Program Medical Research Processes

Presentation
8/9/2016

Recommended Content:

Research and Innovation

Review of the Defense Health Board’s Combat Trauma Lessons Learned from Military Operations of 2001-2013 Report

Presentation
8/9/2016

The in-depth information and recommendations in the report enable [the Office of the Assistant Secretary of Defense for Health Affairs] to consider approaches to enhance Combat Casualty Care.

Recommended Content:

Conditions and Treatments | Research and Innovation | Health Readiness

Joint Trauma System

Presentation
8/9/2016

Recommended Content:

Conditions and Treatments | Research and Innovation

Improving Defense Health Program Medical Research Processes

Presentation
6/2/2016

Recommended Content:

Research and Innovation

Naval Medical Center San Diego Research Activities Challenges and Opportunities

Presentation
2/10/2016

Naval Medical Center San Diego: Research Activities, Challenges, and Opportunities

Recommended Content:

Research and Innovation | Access, Cost, Quality, and Safety
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 6

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.